Publication | Closed Access

Recombinant H7 hemagglutinin expressed in glycoengineered Pichia pastoris forms nanoparticles that protect mice from challenge with H7N9 influenza virus

VaccinationRecombinant H7 HemagglutininImmunologyBiotechnologyVirologyInfluenza VaccineVaccine DesignViral Structural ProteinMedicineH7n9 Influenza Virus